2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

BCM Legacy Fund

Status
ACTIVE
Global HQ
Houston, United States
Countries of investment
  • United States
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Biotechnology
  • Life Sciences
  • Pharma
  • Biology
  • Science
About
BCM Legacy Fund I, LP is an early-stage biomedical venture fund affiliated with Baylor College of Medicine in Houston, managed by Legacy Fund Management Company, LLC and launched in November 2026. It pools philanthropic capital from private foundations and donor-advised funds, with the Greater Houston Community Foundation as its philanthropic partner, and plans to back about 15 early-stage companies over five years. The fund size was not disclosed. Its first investment is Nemea Therapeutics, a Houston spinout of Baylor and the Lead Discovery Center in Germany developing an oral drug for metastatic triple-negative breast cancer.
Min check size
$500K
Max check size
$3M
Fund size
NPS

Investment Thesis

BCM Legacy Fund invests philanthropic capital in biomedical startups built on academic research, especially therapeutics for unmet needs such as rare and pediatric diseases. It backs companies at the earliest and most underfunded stage, sizing each investment to produce a minimum partner-ready dataset so that industry partners, disease foundations or later-stage investors can take over. It differs from conventional venture funds through its philanthropic limited partners, its affiliation with Baylor College of Medicine and its use of innovation maps and AI-assisted diligence to surface overlooked science.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Steve Lehmann previously led the University of Chicago's Innovation Fund and built the venture investments practice at Portal Innovations. Burton Hanson is a Houston entrepreneur and investor and a board member of the Fondren Foundation. Board member Debra McCoy is a former BlackRock managing director and Bain and Company partner, and senior strategic advisor Dr. Paul Klotman is the former president and CEO of Baylor College of Medicine.

BCM Legacy Fund Contacts Information

Primary contact

Secondary contact

Team

Burton Hanson - Managing Partner

Steve Lehmann - Managing Partner

Debra McCoy - Board of Managers

Paul Thomas - Board of Managers

Paul Klotman - Senior Strategic Advisor

Portfolio

Nemea Therapeutics

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp